OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing treatments for patients with gastrointestinal disorders.
1
Funding Rounds
$39.0m
Money raised
Name | Phone | Social networks | |
---|---|---|---|
Ni******* Si*** | - | - | - |
Name | Phone | Social networks | |
---|---|---|---|
Ke***** Wi**** | - | - | - |